Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.

Darios FD, Jorgacevski J, Flašker A, Zorec R, García-Martinez V, Villanueva J, Gutiérrez LM, Leese C, Bal M, Nosyreva E, Kavalali ET, Davletov B

Open source

DOI: 10.1038/s41598-017-05948-z
Published: 2017 Jul 20
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-017-05948-z,
  title = {Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.},
  author = {Darios FD and Jorgacevski J and Flašker A and Zorec R and García-Martinez V and Villanueva J and Gutiérrez LM and Leese C and Bal M and Nosyreva E and Kavalali ET and Davletov B},
  year = {2017},
  journal = {Scientific reports},
  doi = {10.1038/s41598-017-05948-z},
  url = {https://doi.org/10.1038/s41598-017-05948-z}
}

RIS

TY  - JOUR
TI  - Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.
AU  - Darios FD
AU  - Jorgacevski J
AU  - Flašker A
AU  - Zorec R
AU  - García-Martinez V
AU  - Villanueva J
AU  - Gutiérrez LM
AU  - Leese C
AU  - Bal M
AU  - Nosyreva E
AU  - Kavalali ET
AU  - Davletov B
PY  - 2017
JO  - Scientific reports
DO  - 10.1038/s41598-017-05948-z
UR  - https://doi.org/10.1038/s41598-017-05948-z
ER  -

APA

FD, D., J, J., A, F., R, Z., V, G., J, V., LM, G., C, L., M, B., E, N., ET, K., & B, D. (2017). Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.. Scientific reports. https://doi.org/10.1038/s41598-017-05948-z

Source records

pubmed · retrieved 2026-11-10T06:45:51.541Z